Detalhe da pesquisa
1.
Integrated mutational landscape analysis of uterine leiomyosarcomas.
Proc Natl Acad Sci U S A
; 118(15)2021 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33876771
2.
A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.
Cancer
; 128(6): 1206-1218, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34875107
3.
Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.
Br J Cancer
; 126(12): 1695-1703, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35149854
4.
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors.
Proc Natl Acad Sci U S A
; 116(2): 619-624, 2019 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30584090
5.
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy.
Proc Natl Acad Sci U S A
; 116(45): 22730-22736, 2019 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31624127
6.
Alterations in Pre/Post Oxygenator Flows Due to Fibrin Deposition in the CardioHelp System-A Case Report.
J Extra Corpor Technol
; 54(3): 239-241, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36742210
7.
Trastuzumab tolerability in the treatment of advanced (stage III-IV) or recurrent uterine serous carcinomas that overexpress HER2/neu.
Gynecol Oncol
; 163(1): 93-99, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34372971
8.
DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo.
Gynecol Oncol
; 163(2): 334-341, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34452746
9.
Immunotherapy in Cervical Cancer.
Curr Oncol Rep
; 23(6): 61, 2021 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33852056
10.
Novel antibody-drug conjugates: current and future roles in gynecologic oncology.
Curr Opin Obstet Gynecol
; 33(1): 26-33, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32618744
11.
Impact of timing on wound dressing removal after caesarean delivery: a multicentre, randomised controlled trial.
J Obstet Gynaecol
; 41(3): 348-352, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32312139
12.
Comparison of the long-term impact and clinical outcomes of fewer doses and standard doses of human papillomavirus vaccine in the United States: A database study.
Cancer
; 126(8): 1656-1667, 2020 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32037524
13.
Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma.
Gynecol Oncol
; 158(3): 769-775, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32600791
14.
In vitro and in vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma.
Gynecol Oncol
; 156(2): 430-438, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31839338
15.
Targeting human epidermal growth factor receptor 2 (HER2) in gynecologic malignancies.
Curr Opin Obstet Gynecol
; 32(1): 57-64, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31833974
16.
Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.
Br J Cancer
; 130(6): 1073, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38438590
17.
Robotic type II B posterior exenteration for recurrent vaginal cancer.
Gynecol Oncol
; 155(2): 384-385, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31345607
18.
PARP-1 activity (PAR) determines the sensitivity of cervical cancer to olaparib.
Gynecol Oncol
; 155(1): 144-150, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31434613
19.
PI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancers.
Gynecol Oncol
; 153(1): 158-164, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30630630
20.
Understanding the Legal Essentials of a Bowel Injury Lawsuit in Minimally Invasive Gynecologic Surgery.
J Minim Invasive Gynecol
; 25(1): 30-37, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28970057